388 related articles for article (PubMed ID: 22918866)
1. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients.
Robinson CV; Elkins MR; Bialkowski KM; Thornton DJ; Kertesz MA
J Med Microbiol; 2012 Dec; 61(Pt 12):1644-1653. PubMed ID: 22918866
[TBL] [Abstract][Full Text] [Related]
2. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
Sajjan U; Reisman J; Doig P; Irvin RT; Forstner G; Forstner J
J Clin Invest; 1992 Feb; 89(2):657-65. PubMed ID: 1737853
[TBL] [Abstract][Full Text] [Related]
3. Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease.
Flynn JM; Niccum D; Dunitz JM; Hunter RC
PLoS Pathog; 2016 Aug; 12(8):e1005846. PubMed ID: 27548479
[TBL] [Abstract][Full Text] [Related]
4. Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract.
Prince A
Microb Pathog; 1992 Oct; 13(4):251-60. PubMed ID: 1363702
[TBL] [Abstract][Full Text] [Related]
5. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.
Ohman DE; Chakrabarty AM
Infect Immun; 1982 Aug; 37(2):662-9. PubMed ID: 6811437
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
Henderson AG; Ehre C; Button B; Abdullah LH; Cai LH; Leigh MW; DeMaria GC; Matsui H; Donaldson SH; Davis CW; Sheehan JK; Boucher RC; Kesimer M
J Clin Invest; 2014 Jul; 124(7):3047-60. PubMed ID: 24892808
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis.
Palmer GC; Whiteley M
Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350318
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
[TBL] [Abstract][Full Text] [Related]
9. A novel mucin-sulphatase activity found in Burkholderia cepacia and Pseudomonas aeruginosa.
Jansen HJ; Hart CA; Rhodes JM; Saunders JR; Smalley JW
J Med Microbiol; 1999 Jun; 48(6):551-557. PubMed ID: 10359304
[TBL] [Abstract][Full Text] [Related]
10. Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.
Ramphal R; Houdret N; Koo L; Lamblin G; Roussel P
Infect Immun; 1989 Oct; 57(10):3066-71. PubMed ID: 2777373
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs.
Konings AF; Martin LW; Sharples KJ; Roddam LF; Latham R; Reid DW; Lamont IL
Infect Immun; 2013 Aug; 81(8):2697-704. PubMed ID: 23690396
[TBL] [Abstract][Full Text] [Related]
12. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
13. Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis.
Venkatakrishnan V; Packer NH; Thaysen-Andersen M
Expert Rev Respir Med; 2013 Oct; 7(5):553-76. PubMed ID: 24138697
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections.
Davis TJ; Karanjia AV; Bhebhe CN; West SB; Richardson M; Bean HD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33028687
[No Abstract] [Full Text] [Related]
15. Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.
Gifford AH; Willger SD; Dolben EL; Moulton LA; Dorman DB; Bean H; Hill JE; Hampton TH; Ashare A; Hogan DA
Infect Immun; 2016 Oct; 84(10):2995-3006. PubMed ID: 27481238
[TBL] [Abstract][Full Text] [Related]
16. Differential binding of Pseudomonas aeruginosa to normal and cystic fibrosis tracheobronchial mucins.
Devaraj N; Sheykhnazari M; Warren WS; Bhavanandan VP
Glycobiology; 1994 Jun; 4(3):307-16. PubMed ID: 7949656
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the in vivo degradation of human respiratory mucins during Pseudomonas aeruginosa infection.
Houdret N; Ramphal R; Scharfman A; Perini JM; Filliat M; Lamblin G; Roussel P
Biochim Biophys Acta; 1989 Jul; 992(1):96-105. PubMed ID: 2752044
[TBL] [Abstract][Full Text] [Related]
18. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
Sajjan US; Corey M; Karmali MA; Forstner JF
J Clin Invest; 1992 Feb; 89(2):648-56. PubMed ID: 1371125
[TBL] [Abstract][Full Text] [Related]
19. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
Lamont IL; Konings AF; Reid DW
Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
[TBL] [Abstract][Full Text] [Related]
20. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.
Carnoy C; Ramphal R; Scharfman A; Lo-Guidice JM; Houdret N; Klein A; Galabert C; Lamblin G; Roussel P
Am J Respir Cell Mol Biol; 1993 Sep; 9(3):323-34. PubMed ID: 8398170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
